Southwestern internal medicine conference: Endothelial dysfunction and vascular disease

American Journal of the Medical Sciences

Volumn 307, Issue 5, 1994, Pages 378-389

  Meidell, R S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN; ENDOTHELIUM DERIVED RELAXING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NITRIC OXIDE; PROSTACYCLIN; PROTEIN C; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR CELL ADHESION MOLECULE 1;

BLOOD CLOTTING; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL TONE; CELL PROLIFERATION; CONFERENCE PAPER; DIABETES MELLITUS; FIBRINOLYSIS; GENE TRANSFER; HOMOCYSTINURIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 0028295847     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199405000-00013     Document Type: Conference Paper

References (112)

1. R.M.J. Palmer A.G. Ferrige S. Moneada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 528
2. P.R. Myers R.L. Minor Jr. R. Guerra Jr. J.N. Bates D.G. Harrison Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide Nature 345 1990 161 166
3. R.M.J. Palmer D.S. Ashton S. Moneada Vascular endothelial cells synthesize nitric oxide from L-arginine Nature 333 1988 664 668
4. Richard V, Tanner FC, Tschudi M, Liischer TF: Different activation of L-arginine pathway by bradykinin, serotonin, and Clonidine in coronary arteries. Am J Physiol 259:H1433–H1439.
5. D.S. Bredt P.M. Hwang C.E. Glatt C. Lowenstein R.R. Reed S.H. Snyder Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase Nature 351 1991 714 718
6. R.M.J. Rapoport F. Murad Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP Circ Res 52 1983 352 359
7. 2 and prostacyclin Pharmacol Reu 30 1979 293 304
8. Y. Dohi T.F. Lüscher Endothelin-1 in hypertensive resistance arteries: Intraluminal and extraluminal dysfunction Hypertension 18 1991 543 550
9. Z. Yang L. von Segesser E. Bauer P. Stulz M. Turina T.F. Lücher Different activation of endothelial L-arginine and cyclooxygenase pathway in human internal mammary artery and saphenous vein Circ Res 68 1991 52 60
10. T.F. Lüscher F.C. Tanner M.R. Tschudi G. Noll Endothelial dysfunction in coronary artery disease Ann Reu Med 44 1993 395 418
11. M. Yanagisawa H. Kurihara S. Kimura Y. Tomobe M. Kobayashi Y. Mitsui Y. Yazaki K. Goto T. Masaki A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 414
12. Z. Yang Z. Bauer L. von Segesser P. Stulz M. Turina T.F. Lücher Different mobilization of calcium in endothelin-1 induced contractions in human arteries and veins: effects of calcium antagonists J Cardiovasc Pharmacol 16 1990 654 660
13. C. Boulanger T.F. Lüscher Release of endothelin from the porcine aorta: Inhibition by endothelium-derived nitric oxide J Clin Invest 85 1990 587 594
14. J.L. Amezcua R.M. Palmer B.M. de Souza S. Moneada Nitric oxide synthesized from l -arginine regulates vascular tone in the coronary circulation of the rabbit Br J Pharmacol 97 1989 1119 1124
15. D.D. Rees R.M.J. Palmer S. Moneada Role of endothelium-derived nitric oxide in the regulation of blood pressure Proc Natl Acad Sci U S A 86 1989 3375 3381
16. G.E. Palade Transport of macromolecules across the vascular endothelium Proceedings of the VIIth International Symposium on the Biology of Vascular Cells , San Diego, November 10–14 1992
17. N. Niimi N. Noso S. Yamamoto The effect of histamine on cultured endothelial cells: A study of the mechanism of increased vascular permeability Eur J Pharmacol 221 1992 325 331
18. N. Suttorp U. Weber T. Welsch C. Schudt Role of phosphodiesterases in the regulation of endothelial permeability in vitro J Clin Invest 91 1993 1421 1428
19. A receptor Eur J Pharmacol 219 1992 343 344
20. T.A. Springer Adhesion receptors of the immune system Nature 346 1990 425 434
21. M.I. Cybulsky M.A. Gimbrone Endothelial expression of a mononuclear leukocyte adhesion molecular during atherogenesis Science 251 1991 788 791
22. T.A. Springer L.A. Lasky Sticky sugars for selectins Nature 349 1991 196 197
23. E. Ruoslahti Integrins J Clin Invest 87 1991 1 5
24. M.B. Lawrence T.A. Springer Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins Cell 65 1991 859 873
25. T.N. Mayadas R.C. Johnson H. Rayburn R.O. Hynes D.D. Wagner Leukocyte rolling and extravasation are severely compromised in P-selectin deficient mice Cell 74 1993 541 554
26. M.P. Bevilacqua S. Stengelin M.A. Gimbrone Jr. B. Seed Endothelial leukocyte adhesion molecule-1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins Science 243 1989 1160 1165
27. D.E. Staunton S.D. Marlin S. Stratowa M.L. Dustin T.A. Springer Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families Cell 52 1988 925 933
28. L. Osborn C. Hession R. Tizard C. Vassalio S. Luhowskyj G. Chi-Rosso R. Lobb Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds lymphocytes Cell 59 1989 1203 1211
29. J.S. Prober M.R. Slowik L.G. DeLuca A.J. Ritchie Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1 J Immunol 150 1993 5114 5123
30. T.J. Williams P.G. Hellewell Endothelial cell biology: Adhesion molecules involved in the microvascular inflammatory response Am Rev Respir Dis 146 1992 S45 S50
31. B.L. Nguyen M. Saitoh J.A. Ware Interaction of nitric oxide and cGMP with signal transduction in activated platelets Am J Physiol 261 1991 H1043 H1052
32. W. Durante M.H. Kroll P.M. Vanhoutte A.L. Schäfer Endothelium-derived relaxing factor inhibits thrombin induced platelet aggregation by inhibiting platelet phospholipase C Blood 79 1992 110 116
33. C. Nolte M. Eigenthaler P. Schanzenbacher U. Walter Endothelial cell-dependent phosphorylation of a platelet protein mediated by cAMP- and cGMP elevating factors J Biol Chem 266 1991 14808 14812
34. R. Bowen R.J. Haslam Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood: Role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin El FASEB J 3 1989 2389 2400
35. W.A. Dittman P.W. Majerus Structure and function of thrombomodulin: A natural anticoagulant Blood 75 1990 329 336
36. A.J. Marcus L.B. Safier K.A. Hajjar H.L. Ullman N. Islam M.J. Broekman A.M. Eiroa Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase: Thromboregulation by endothelial cells J Clin Invest 88 1991 1690 1696
37. 2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells Lab Invest 42 1980 366 374
38. R. Pytela M.D. Pierschbacher M.H. Ginsberg E.F. Plow E. Rouslahti Platelet membrane glycoprotein IIb/IIIa: Member of a family of Arg-Gly-Asp-specific adhesion receptors Science 231 1986 1559 1562
39. K. Titani K. Takio M. Hnada Z.M. Ruggeri Amino acid sequence of the von Willebrand factor-binding domain of platelet membrane glycoprotein lb Proc Natl Acad Sci U S A 84 1987 5610 5614
40. ++ associated with von Willebrand factor release in human endothelial cells exposed to histamine: study of microcarrier cell monolayers using the fluorescent prove indo-1 J Clin Invest 79 1987 600 608
41. S.M. Prescott G.A. Zimmerman T.M. Mclyntyre Platelet-activating factor J Biol Chem 265 1990 17381 17384
42. D.M. Stern P. Nawroth J. Marcum D. Handley W. Kisiel R. Rosenberg K. Stern Interaction of antithrombin III with bovine aortic segments: Role of heparin in binding and enhanced anticoagulant activity J Clin Invest 75 1985 272 279
43. R.D. Rosenberg Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism Am J Med 87 1989 2S 9S
44. ++ binding to a high affinity site that does not contain gamma-carboxyglutamic acid J Biol Chem 258 1983 5554 5560
45. K.W. Harris C.T. Esmon Protein S is required for bovine platelets to support activated protein C binding and activity J Biol Chem 260 1985 2007 2010
46. T.M. Hackeng M. Hessing C. van’t Veer F. Meijer-Huizinga J.C.M. Meijers P.G. deGroot J.A. van Mourik B.N. Bouma Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein C J Biol Chem 268 1993 3993 4000
47. D.M. Stern P.P. Nawroth K. Harris C.T. Esmon Cultured bovine aortic endothelial cells promote activated protein C-protein S-mediated inactivation of factor Va J Biol Chem 261 1986 713 718
48. F.J. Walker Regulation of activated protein C by protein S: Role of phospholipid in factor Va inactivation J Biol Chem 256 1981 11128 11131
49. F.J. Castellino Biochemistry of human plasminogen Semin Thromb Hemost 10 1984 18 23
50. R.D. Gerard R.S. Meidell Regulation of tissue plasminogen activator expression Ann Rev Physiol 51 1989 245 262
51. M. Hanss D. Collen Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: Modulation by thrombin, endotoxin and histamine J Lab Clin Med 109 1987 97 108
52. S.L. Diamond S.G. Eskin L.V. McIntire Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells Science 243 1989 1483 1485
53. D. Dichek T. Quertermous Thrombin regulation of mRNA levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells Blood 74 1989 222 228
54. K.A. Hajjar N.H. Hamel Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase J Biol Chem 265 1990 2908 2916
55. K.A. Hajjar The endothelial cell tissue plasminogen activator receptor: Specific interactions with plasminogen J Biol Chem 266 1991 21962 21970
56. T.D. Gelehrter R. Sznycer-Laszuk Thrombin induction of plasminogen activator inhibitor in cultured human endothelial cells J Clin Invest 77 1986 165 169
57. F.X. Reido R.S. Munford W.B. Campbell J.S. Reisch K.R. Chien R.D. Gerard Deacylated lipopolysaccharide inhibits plasminogen activator inhibitor-1, prostacyclin, and prostaglandin E2 induction by lipopolysaccharide but not by tumor necrosis factor- α J Immunol 144 1990 3506 3512
58. E.K.O. Kruithof C. Tran-Thang F. Bachmann Studies on the release of plasminogen activator inhibitor by human platelets Thromb Haemost 55 1986 201 205
59. P.F. Davies Vascular cell interactions with special reference to the pathogenesis of atherosclerosis Lab Invest 55 1986 5 24
60. J.G. De Mey P.M. Schiffers Effects of the endothelium on growth responses in arteries J Cardiovasc Pharmacol 21 suppl 1 1993 S22 S25
61. J.H. Chamley-Campbell G.R. Campbell R. Ross Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens J Cell Biol 89 1981 379 383
62. J.G.R. De May E.H. Dijkstra M.J.J.F. Vrijdag Endothelium reduces DNA synthesis in isolated arteries Am J Physiol 260 1991 H1128 H1134
63. J.G.R. De May M.P. Uitendaal H.C.M. Boonen M.J.J.F. Vrijdag M.J.A.P. Daemen H.A.J. Struijker Boudier Growth responses in isolated elastic, muscular and resistance-sized arterial segments of the rat Blood Vessels 28 1991 372 385
64. D.H. Ausprunk C.L. Boudreau D.A. Nelson Proteoglycans in the microvasculature: Histochemical localization in microvessels of the rabbit eye Am J Pathol 103 1981 353 366
65. M. Richardson I. Ihnatowycz S. Moore Glycosaminoglycan distribution in rabbit aortic wall following balloon catheter de-endothelialization: An ultrastrutural study Lab Invest 43 1980 509 516
66. M. Stemerman T.H. Spaet F. Pitlick I. Cibtron I. Lejnieks M.L. Tiell Intimai healing: The pattern of re-endothelialization and intimai thickening Am J Pathol 87 1977 125 142
67. A.W. Clowes M.A. Reidy M. Clowes Kinetics of cellular proliferation after arterial injury: Smooth muscle growth in the absence of endothelium Lab Invest 49 1983 327 333
68. A.W. Clowes S.M. Schwartz Significance of quiescent smooth muscle migration in the injured rat carotid artery Circ Res 56 1985 139 145
69. J.A. Fishman G.B. Ryan M.J. Karnorsky Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening Lab Invest 32 1977 339 351
70. L.N. Walker M.M. Ramsey D.E. Bowyer Endothelial healing following defined injury to rabbit aorta: Depth of injury and mode of repair Atherosclerosis 47 1983 123 130
71. T. Collins J.S. Prober M.A. Gimbrone C. Betsholtz B. Westermark C.H. Heldin Cultured human endothelial cells express platelet-derived growth factor A chain Am J Pathol 126 1987 7 12
72. J.N. Wilcox K.M. Smith L.T. Williams S.M. Schwartz D. Gordon Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in-situ hybridization J Clin Invest 82 1988 1134 1143
73. T. Collins Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion Lab Invest 68 1993 499 508
74. A.M. Lefer X.L. Ma Cytokines and growth factors in endothelial dysfunction Crit Care Med 21 suppl 2 1993 S9 S14
75. R.S. Berman W. Martin Arterial endothelial barrier dysfunction: Actions of homocysteine and the hypoxanthine-xanthine oxidase free radical generating system Br J Pharmacol 108 1993 920 926
76. J.R. Bradley D.R. Johnson J.S. Pober Endothelial activation by hydrogen peroxide. Selective increases of intercellular adhesion molecule-1 and major histocompatibility complex class I Am J Pathol 142 1993 1598 1609
77. W.F. Westlin M.A. Gimbrone Jr. Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation Am J Pathol 142 1993 117 128
78. K. Kugiyama S.A. Kerus J.D. Morrisett R. Roberts P.D. Henry Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins Nature 344 1990 160 164
79. F.C. Tanner G. Noll C.M. Boulager T.F. Lüscher Oxidized native low density lipoproteins inhibit relaxations of porcine coronary arteries: Role of scavenger receptor and endothelium-derived nitric oxide Circulation 83 1991 2012 2019
80. N. Kume M.I. Cybulsky M.A. Gimbrone Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit endothelial cells J Clin Invest 90 1992 1138 1144
81. H. Li M.I. Cybulsky M.A. Gimbrone Jr. P. Libby An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium Arterioscler Thromb 13 1993 197 204
82. M.I. Cybulsky M.A. Gimbrone Endothelial expression of a mononuclear leukocyte adhesion molecular during atherogenesis Science 251 1991 788 791
83. C. Bossaler G.B. Habib H. Yamamoto C. Williams S. Wells P.D. Henry Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5’-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta J Clin Invest 79 1987 170 178
84. H. Yamamoto C. Bossaller J. Cartwright Jr. P.D. Henry Video-microscopic demonstration of defective cholinergic arteriolar vasodilation in atherosclerotic rabbit J Clin Invest 81 1988 1752 1758
85. G.A. FitzGerald B. Smith A.K. Pedersen A.R. Brash Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation N Engl J Med 310 1984 1065 1068
86. P. Golino F. Piscione J.T. Willerson M. Cappelli-Bigazzi A. Focaccio B. Villari C. Indolfi E. Russolillo M. Condorelli M. Chiariello Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients N Engl J Med 324 1991 641 648
87. L.N. Wright Cell biology of arterial proteoglycans Arteriosclerosis 9 1989 1 20
88. J.A. Panza P.R. Casino D.M. Badar A.A. Quyyumi Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension Circulation 87 1993 1475 1481
89. J.A. Panza P.R. Casino C.M. Kilcoyne A.A. Quyyumi Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension Circulation 87 1993 1468 1474
90. M. Jameson F.X. Dai T. Lüscher J. Skopec A. Diederich D. Diederich Endothelium-derived contracting factors in resistance arteries of young spontaneously hypertensive rats before development of overt hypertension Hypertension 21 1993 280 288
91. R. Bucala K.J. Tracey A. Cerami Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes J Clin Invest 87 1991 432 438
92. B. Tesfamariam M.L. Brown D. Deykin R.A. Cohen Elevated glucose promotes generation of vasoconstrictor prostanoids in rabbit aorta J Clin Invest 85 1990 929 932
93. S.H. Mudd F. Skovby H.L. Levy K.D. Pettigrew B. Wilcken R.E. Pyeritz G. Andria G.H.L. Boers I.L. Bromberg R. Cerone B. Fowler H. Grobe H. Schmidt L. Schweitzer The natural history of homocystinuria due to cystathionine β -synthase deficiency Am J Hum Genet 37 1985 1 31
94. M.R. Malinow S.S. Kang L.M. Taylor P.W.K. Wong B. Coull T. Inahara C. Mukerjee G. Sexton B. Upson Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease Circulation 79 1989 1180 1188
95. G.H.L. Boers A.G.H. Smals F.J.M. Trijbels B. Fowler J.A.J.M. Bakkeren H.C. Schoonderwaldt W.J. Kleijer P.W.C. Kloppenborg Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease N Engl J Med 313 1985 709 715
96. J.J. Genest J.R. McNamara D.N. Salem P.W.F. Wilson E.J. Schaefer R. Malinow Plasma homocyst(e)ine levels in men with premature coronary artery disease J Am Coll Cardiol 16 1990 1114 1119
97. P.G. DeGroot C. Willems G.H.J. Boers M.D. Gonsalves W.G. Van Aken J.A. Van Mourik Endothelial cell dysfunction in homocystinuria Eur J Clin Invest 13 1983 405 410
98. K.A. Hajjar Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor J Clin Invest 91 1993 2873 2879
99. J.S. Stamler J.A. Osborne O. Jaraki L.E. Rabbani M. Mullins D. Singel J. Loscalzo Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen J Clin Invest 91 1993 308 318
100. R. Clarke L. Daly K. Robinson E. Naughten S. Cahalane B. Fowler I. Graham Hyperhomocystinuria: An independent risk factor for vascular disease N Engl J Med 324 1991 1149 1155
101. J.W. Heinecke H. Rosen L.A. Suzuki A. Chait The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells J Biol Chem 262 1987 10098 10103
102. G.M. Rodgers M.T.P. Conn Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells Blood 75 1990 895 901
103. T. Hayashi G. Honda K. Suzuki An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells Blood 79 1992 2930 2936
104. S.R. Lentz J.E. Sadler Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum Blood 81 1993 683 689
105. Y. Matsuda K. Hirata N. Inoue M. Suematsu S. Kawashima H. Akita M. Yokoyama High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation Circ Res 72 1993 1103 1109
106. E.G. Nabel G. Plautz F.M. Boyce J.C. Stanley G.J. Nabel Recombinant gene expression in-vivo within endothelial cells of the arterial wall Science 244 1989 1342 1344
107. E.G. Nabel G. Plautz G.J. Nabel Site-specific gene expression in vivo by direct gene transfer into the arterial wall Science 249 1990 1285 1288
108. E.G. Nabel G. Plautz G.J. Nabel Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis Proc Natl Acad Sci U S A 89 1992 5157 5161
109. P. Lemarchand H.A. Jaffe C. Danel M.C. Cid H.K. Kleinman L.D. Stratford-Perricaudet M. Perricaudet A. Pavirani J.P. Lecocq R.G. Crystal Adenovirus-mediated transfer of a recombinant human α 1-antitrypsin cDNA to human endothelial cells Proc Natl Acad Sci U S A 89 1992 6482 6486
110. J.E. Willard M.E. Jessen R.D. Gerard R.S. Meideil Recombinant adenovirus is an efficient vector for in vivo gene transfer and can be preferentially directed at vascular endothelium or smooth muscle cells Circulation suppl 1 1992 473 4473
111. J. Herz R.D. Gerard Adenovirus-mediated low density lipoprotein receptor gene transfer accelerates cholesterol clearance in normal mice Proc Natl Acad Sci U S A 90 1993 2812 2816
112. S. Ishibashi M.S. Brown J.L. Goldstein R.D. Gerard R.E. Hammer J. Herz Hypercholesterolemia in LDL receptor knockout mice and its reversal by adenovirus-mediated gene delivery J Clin Invest 92 1993 866 871